Keyphrases
Alzheimer's Disease
79%
Blood-brain Barrier
79%
125I
39%
Amyloid Plaques
34%
Endothelium
33%
Insulin
27%
Amyloid-β Peptide
26%
Amyloid Protein
24%
Alzheimer's Disease Model
21%
Cerebral Amyloid Angiopathy
20%
Alzheimer's Disease Brain
20%
Nanovehicles
18%
Amyloid beta
17%
Endothelial Cells
15%
Intraneuronal
14%
Insulin Signaling
14%
Plaque
14%
Melatonin
13%
Neurodegeneration
13%
Cerebral Vasculature
13%
Endocytosis
12%
Amyloid Deposition
12%
Alzheimer's Disease Pathology
11%
Fluorescein
10%
Olfactory mucosa
10%
Contrast Agent
10%
Plasma Pharmacokinetics
10%
Scopolamine
9%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
9%
Mimetic Peptide
9%
Gut Microbiota
9%
Antibody Fragment
9%
High-density Lipoprotein Cholesterol (HDL-C)
9%
Plaque Targeting
9%
Transdermal Drug Delivery
9%
Single-photon Emission Computed Tomography (SPECT)
8%
Neurodegenerative Diseases
8%
Neuronal Uptake
8%
Brain Pharmacokinetics
8%
Hippocampal Neurons
8%
Neuronal Cells
7%
Deconvolution
7%
Insulin Receptor
7%
Polyamines
7%
Blood-brain Barrier Disruption
7%
Monoclonal Antibody
6%
Chitosan
6%
APPPS1
6%
P-glycoprotein (P-gp)
6%
Apolipoprotein A-I (ApoA-I)
6%
Neuroscience
Alzheimer's Disease
100%
Amyloid Protein
84%
Blood Brain Barrier
71%
Iodine-125
31%
Blood Plasma
26%
Pharmacokinetics
23%
Beta Amyloid
16%
Insulin Signaling
15%
Endocytosis
13%
Cerebral Amyloid Angiopathy
12%
Contrast Medium
11%
In Vitro
10%
Fluorescein
10%
Amyloid Beta Protein
10%
In Vivo
9%
High-Density Lipoprotein
9%
Molecular Imaging
9%
Insulin Receptor
7%
Neurodegeneration
7%
Amino Terminal Sequence
7%
Monoclonal Antibody
7%
Positron Emission Tomography
6%
Neurodegenerative Disorder
6%
Internalization
6%
Apolipoprotein A
6%
Magnetic Resonance Imaging
6%
Polyamine
6%
Histidine
6%
Computed Tomography
5%
Synapsin I
5%
Putrescine
5%
Immunotherapy
5%
Kinase
5%
Clathrin
5%